Louisbourg Investments Inc. Royalty Pharma PLC Transaction History
Louisbourg Investments Inc.
- $368 Billion
- Q1 2025
A detailed history of Louisbourg Investments Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Louisbourg Investments Inc. holds 905 shares of RPRX stock, worth $29,448. This represents 0.01% of its overall portfolio holdings.
Number of Shares
905Holding current value
$29,448% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding RPRX
# of Institutions
454Shares Held
295MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.29 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.22 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$749 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$552 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$460 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.2B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...